IRAZÚ ONCOLOGY
Live / Applied — Second extension granted (statement of use) (as of 12 Feb 2026)
What this means for you
Not registered yet, but its 11 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98218923
- Mark type
- Design + words
- Filed
- 11 Oct 2023
- Published for opposition
- 17 Dec 2024
- Attorney of record
- Nicholas B. Hawkins
Goods and services
- Class 001 — Chemicals: Bacteria that produce outer membrane vesicles bearing tumor antigens on their surface to destroy tumor cells for research purposes
- Class 005 — Pharmaceuticals: Bacteria that produce outer membrane vesicles bearing tumor antigens on their surface to destroy tumor cells for medical purposes
Owner
- Irazu Oncology, LLC, Baltimore, MD, US
- Irazu Oncology, LLC, Baltimore, MD, US
Prosecution history
- 12 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Feb 2026 — SOU EXTENSION 2 GRANTED
- 11 Feb 2026 — SOU EXTENSION 2 FILED
- 11 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Aug 2025 — SOU EXTENSION 1 GRANTED
- 11 Aug 2025 — SOU EXTENSION 1 FILED
- 11 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Dec 2024 — PUBLISHED FOR OPPOSITION
- 11 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE